TELA Bio, Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
TELA Bio, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • TELA Bio, Inc. Operating Margin for the quarter ending September 30, 2024 was -55.4 %, a 28.7% increase year-over-year.
  • TELA Bio, Inc. annual Operating Margin for 2023 was -75.4 %, a 19.9% increase from 2022.
  • TELA Bio, Inc. annual Operating Margin for 2022 was -94.2 %, a 5.78% increase from 2021.
  • TELA Bio, Inc. annual Operating Margin for 2021 was -100 %, a 28% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -55.4 +22.3 +28.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -60 +22.4 +27.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -59.6 +30 +33.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -75.4 +18.8 +19.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -77.7 +19.8 +20.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -82.4 +18.4 +18.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -89.6 +11 +11% Jan 1, 2023 Mar 31, 2023
Q4 2022 -94.2 +5.78 +5.78% Oct 1, 2022 Dec 31, 2022
Q3 2022 -97.5 +9.17 +8.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -101 +14.6 +12.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -101 +27.2 +21.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -100 +38.8 +28% Oct 1, 2021 Dec 31, 2021
Q3 2021 -107 +33.2 +23.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -115 +17.4 +13.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -128 +1.19 +0.92% Jan 1, 2021 Mar 31, 2021
Q4 2020 -139 -14.7 -11.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -140 Jul 1, 2020 Sep 30, 2020
Q2 2020 -133 Apr 1, 2020 Jun 30, 2020
Q1 2020 -129 Jan 1, 2020 Mar 31, 2020
Q4 2019 -124 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.